别名:Complement component C9, Complement component C9a, Complement component C9b, C9应用:WB,IHC
反应种属:Human
规格:50μl/100μl
Description |
---|
This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq]. |
Specification | |
---|---|
Aliases | Complement component C9, Complement component C9a, Complement component C9b, C9 |
Entrez GeneID | 735 |
Swissprot | P02748 |
WB Predicted band size | 63.2kDa |
Host/Isotype | Rabbit IgG |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This C9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 191-220 amino acids from the Central region of human C9. |
Formulation | Purified polyclonal antibody supplied in PBS with 0.05% sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Application | |
---|---|
WB | 1/1000 |
IHC | 1/100-1/500 |
![]() |
Anti-C9 Antibody (Center) at 1:1000 dilution + human liver lysate
Lysates/proteins at 20 µg per lane. Secondary Predicted band size : 63 kDa Blocking/Dilution buffer: 5% NFDM/TBST. |
![]() |
C9 Antibody (Center) (Cat. #P33613) western blot analysis in ZR-75-1 cell line lysates (35ug/lane).This demonstrates the C9 antibody detected the C9 protein (arrow). |
![]() |
C9 Antibody (Center) (P33613)immunohistochemistry analysis in formalin fixed and paraffin embedded human placenta tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of C9 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复